PPARγ activation by lipolysis-generated ligands is required for cAMP dependent UCP1 induction in human thermogenic adipocytes

Anand Desai,Zinger Yang Loureiro,Tiffany DeSouza,Qin Yang,Javier Solivan-Rivera,Silvia Corvera
DOI: https://doi.org/10.1101/2024.08.10.607465
2024-08-11
Abstract:Objective: The uncoupling protein 1 (UCP1) is induced in brown or beige adipocytes through catecholamine-induced cAMP signaling, which activates diverse transcription factors. UCP1 expression can also be enhanced by PPARγ agonists such as rosiglitazone (Rsg). However, it is unclear whether this upregulation results from de-novo differentiation of beige adipocytes from progenitor cells, or from the induction of UCP1 in pre-existing adipocytes. To explore this, we employed human adipocytes differentiated from progenitor cells and examined their acute response to Rsg, to the adenylate-cyclase activator forskolin (Fsk), or to both simultaneously. Methods: Adipocytes generated from primary human progenitor cells were differentiated without exposure to PPARγ agonists, and treated for 3, 6 or 78 hours to Fsk, to Rsg, or to both simultaneously. Bulk RNASeq, RNAScope, RT-PCR, CRISPR-Cas9 mediated knockout, oxygen consumption and western blotting were used to assess cellular responses. Results: UCP1 mRNA expression was induced within 3 hours of exposure to either Rsg or Fsk, indicating that the Rsg effect is independent on additional adipocyte differentiation. Although Rsg and Fsk induced distinct overall transcriptional responses, both induced genes associated with calcium metabolism, lipid droplet assembly, and mitochondrial remodeling, denoting core features of human adipocyte beiging. Unexpectedly, we found that Fsk-induced UCP1 expression was reduced by approximately 80% following CRISPR-Cas9-mediated knockout of PNPLA2, the gene encoding the triglyceride lipase ATGL. As anticipated, ATGL knockout suppressed lipolysis; however, the associated suppression of UCP1 induction indicates that maximal cAMP-mediated UCP1 induction requires products of ATGL-catalyzed lipolysis. Supporting this, we observed that the reduction in Fsk-stimulated UCP1 induction caused by ATGL knockout was reversed by Rsg, implying that the role of lipolysis in this process is to generate natural PPARγ agonists. Conclusion: UCP1 transcription is known to be stimulated by transcription factors activated downstream of cAMP-dependent protein kinases. Here we demonstrate that UCP1 transcription can also be acutely induced through PPARγ-activation. Moreover, both pathways are activated in human adipocytes in response to cAMP, synergistically inducing UCP1 expression. The stimulation of PPARγ in response to cAMP occurs as a result of the production of natural PPARγ-activating ligands through ATGL-mediated lipolysis.
Cell Biology
What problem does this paper attempt to address?
### The problems the paper attempts to solve This paper aims to explore whether the activation of PPARγ (peroxisome proliferator - activated receptor γ) is required for cAMP - dependent UCP1 (uncoupling protein 1) induction in human thermogenic adipocytes. Specifically, the researchers hope to answer the following questions: 1. **The effect of PPARγ activation on UCP1 expression**: Can PPARγ agonists (such as rosiglitazone, Rsg) acutely induce UCP1 expression in differentiated adipocytes, or does it mainly increase UCP1 levels by promoting the differentiation of new beige adipocytes from progenitor cells? 2. **The relationship between the cAMP signaling pathway and PPARγ activation**: How does the cAMP signaling pathway interact with PPARγ activation to induce UCP1 expression? In particular, does the cAMP signaling pathway activate PPARγ through natural ligands generated by lipolysis? ### Research background - **The function of UCP1**: UCP1 is expressed in brown or "beige" adipocytes and generates heat by uncoupling the electron transport chain, thereby achieving non - shivering thermogenesis. - **The cAMP signaling pathway**: Catecholamines (such as norepinephrine) activate multiple transcription factors through the cAMP signaling pathway and ultimately induce UCP1 expression. - **The role of PPARγ**: PPARγ agonists (such as Rsg) can also enhance UCP1 expression, but the mechanism is not yet clear. ### Research methods To answer the above questions, the researchers used adipocytes differentiated from human progenitor cells and conducted the following experiments: - **Treatment conditions**: The cells were treated with Fsk (adenylyl cyclase activator), Rsg, or both simultaneously for 3, 6, or 78 hours. - **Detection methods**: Cell responses were evaluated by techniques such as Bulk RNASeq, RNA in - situ hybridization (RNAscope), RT - PCR, CRISPR - Cas9 - mediated knockout, oxygen consumption measurement, and Western blotting. ### Main findings 1. **Acute induction of UCP1 expression**: Both Rsg and Fsk can acutely induce UCP1 mRNA expression within 3 hours, indicating that the effect of Rsg is independent of additional adipocyte differentiation. 2. **The crucial role of lipolysis**: By knocking out ATGL (the gene encoding triacylglycerol lipase ATGL) using CRISPR - Cas9, it was found that Fsk - induced UCP1 expression was significantly reduced by approximately 80%, suggesting that maximal cAMP - mediated UCP1 induction requires ATGL - catalyzed lipolysis products. 3. **Synergistic effect**: Rsg can reverse the inhibition of Fsk - stimulated UCP1 expression caused by ATGL knockout, implying that lipolysis generates natural PPARγ agonists in this process. 4. **Common regulatory mechanism**: The cAMP signaling pathway synergistically induces UCP1 expression by activating PPARγ and other transcription factors. ### Conclusion This study reveals that UCP1 transcription can be acutely induced through PPARγ activation and that this induction acts in synergy with the cAMP signaling pathway. More importantly, cAMP - stimulated PPARγ is achieved through natural ligands generated by ATGL - mediated lipolysis. These findings contribute to understanding the regulatory mechanism of UCP1 expression in human adipocytes and provide a theoretical basis for the development of new treatment methods for metabolic diseases. ### Keywords Thermogenesis, Brown adipose tissue, Beige adipose tissue, Hormone signaling, Catecholamines, Natural ligands, Nuclear receptors